Related Experiment Video
Updated: Aug 6, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Single-day therapy for recurrent genital herpes
Stephen Tyring1, Tim Berger, Angela Yen-Moore
1Department of Dermatology, University of Texas Health Science Center, Houston, Texas 77058, USA. styring@ccstexas.com
Single-day famciclovir treatment for genital herpes significantly reduces healing time and symptom duration. This convenient, patient-initiated approach offers comparable or superior results to multi-day therapies, improving outbreak management.
Area of Science:
- Virology
- Dermatology
- Public Health
Background:
- Genital herpes is a prevalent, incurable viral infection impacting public health.
- Current episodic treatment with nucleoside analogs typically lasts 3-5 days.
- Optimal treatment timing is crucial, as maximum viral replication occurs within 24 hours of symptom onset.
Purpose of the Study:
- To evaluate the effectiveness of patient-initiated single-day famciclovir versus placebo for genital herpes treatment.
- To assess the impact of single-day therapy on healing time, symptom duration, and outbreak progression.
Main Methods:
- A study compared patient-initiated single-day famciclovir to a placebo.
- Effectiveness was measured by healing time, symptom duration, and the proportion of patients avoiding full outbreaks.
Main Results:
- Single-day famciclovir significantly decreased healing time and symptom duration.
- It also increased the proportion of patients who did not progress to a full outbreak.
- Results were comparable or superior to conventional 2-5 day therapies.
Conclusions:
- Patient-initiated single-day famciclovir is an effective treatment for genital herpes.
- This approach offers convenience, potentially improving patient adherence and overall management of recurrent outbreaks.
Related Concept Videos
Genital Herpes
Herpes
Trichomoniasis
Sexually Transmitted Infections
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Retrovirus Life Cycles

